Dr. Ashish Kumar Goel
Professor
MBBS MD DM (Gastroenterology) Ph.D (Hepatology)
ORCID ID: 0000-0003-1659-2103
Linkedin: linkedin.com/in/dr-ashish-goel-658050143
Department: Hepatology
Department Phone No: +91-0417-2224854
Location: Christian Medical College, Main campus, Ida Scudder Road, Vellore, India
Skills and Expertise
Dr. Ashish Goel is a clinician scientist specializing in the field Hepatology. With a Ph.D. (The TN Dr.MGR Medical University, India) and International Training Fellowship (Birmingham,UK), he has over 15 years of research experience in variety of liver diseases. Initially, research focus was on non-cirrhotic portal hypertension, an ‘Indian’ disease, where a complex interplay of poverty, gut inflammation and portal hypertension was decoded. Currently, he is studying role of innate immune hyper-activation in liver failure and measures to ameliorate with an aim to improve survival. Plasma-exchange has now been implemented as ‘Hub and Spoke’ across Tamil Nadu for rodenticide-induced liver-failure. Additionally, he is part of multiple national and international collaborative studies. He is a conferred Fellow of national bodies (FISG, FINASL) and has played an active part in formulating national and international guidelines on management of liver diseases. He is member of Technical Expert Group for NAFLD (under MOHFW, GOI, May 2024) and state Experts Committee for Liver Transplant (TRANSTAN). He has multiple publications in books and journals and has received competitive national grants and multiple awards. He is currently serving on the editorial board of Journal of Clinical and Experimental Hepatology, Indian Journal of Gastroenterology etc. He is mentoring multiple DM and Ph.D students through their research. He hopes to leverage his knowledge and position to positively impact life of liver disease patients.
Publications
1. Bajaj JS, Choudhury AK, Xie Q, et al. Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium, The Lancet Gastroenterology & Hepatology, 2023, ISSN 2468-1253, https://doi.org/10.1016/S2468-1253(23)00098-5. 2. Aaron, R., Premkumar, K., Chapla, A. et al. Focused panel sequencing points to genetic predisposition in non-cirrhotic intrahepatic portal hypertension patients in India. Indian J Gastroenterol (2023). https://doi.org/10.1007/s12664-023-01454-5 3. Goel A, Madhu K, Zachariah U, Sajith KG, Ramachandran J, Ramakrishna B, Gibikote S, Jude J, Chandy GM, Elias E, Eapen CE. A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India. Indian J Med Res 2013;137:922-7 4. Marta Magaz; Heloïse Giudicelli-Lett; Juan G. Abraldes; Oana Nicoară-Farcău; Fanny Turon; Neil Rajoriya; Ashish Goel; Karlien Raymenants; Sophie Hillaire; Luis Téllez et al. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome. Journal of Hepatology; DOI: 10.1016/j.jhep.2024.07.035 5. Alexander, V., Chellaiya, G.K., Gnanadeepam, S. et al. On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange. Indian J Gastroenterol (2024). https://doi.org/10.1007/s12664-024-01585-3 6. Satish SP, Narayanasamy K, Thurai S.M, Raghunathan S, Jeyalydia J, Magaiyakarasi A et al. The “Hub and Spoke” model: a pathway for urgent plasma exchange to treat patients with rodenticide ingestion induced acute liver failure in Tamil Nadu, India. The Lancet Regional Health – Southeast Asia 2024 (Ahead of print)